EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond the Spotlight: Enterobacter spp. as Overlooked Carbapenemase Producers in Europe

Ivana Cirkovic iD, Snezana Brkic iD

Antibiotics · 18.10.2025 · 14 (10) · 1045

DOI: 10.3390/antibiotics14101045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 18.10.2025. Verfasst von Ivana Cirkovic und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) poses a critical global health challenge, with carbapenemase-producing Enterobacterales (CPE) representing one of the most urgent threats. While Klebsiella pneumoniae and Escherichia coli have been the focus of most surveillance programs, Enterobacter spp., members of the Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli (ESKAPEE) group, remain an underrecognized but increasingly important reservoir of carbapenemase genes in Europe. Despite being categorized by the World Health Organization (WHO) as “critical-priority” pathogens, Enterobacter spp. are largely excluded from major AMR surveillance frameworks, creating blind spots in detection and control. This review summarizes the taxonomy, intrinsic resistance mechanisms, and clinical relevance of Enterobacter spp., with a particular focus on carbapenemase epidemiology across Europe. We highlight the distribution and genetic context of major carbapenemases, including VIM, OXA-48-like, KPC, and NDM, and discuss emerging or minor enzymes such as IMI, FRI, GES, and IMP. Epidemiological data reveal shifting dominance patterns over time, with VIM enzymes consolidating their prevalence after 2015, while OXA-48-like and KPC declined, and NDM gained ground. The genetic diversity of Enterobacter spp., coupled with their ability to act as both nosocomial pathogens and silent intestinal or environmental reservoirs, facilitates the dissemination of carbapenemase genes via epidemic plasmids and clonal expansion. Addressing the growing impact of carbapenemase-producing Enterobacter spp. requires their systematic inclusion in national and international monitoring programs, expanded use of genomic epidemiology in clinical microbiology, and better alignment between research, clinical practice, and policy. A One Health approach is essential to curb the spread of carbapenemases across human, environmental, and animal reservoirs, and to safeguard the remaining therapeutic options.

Schlagwörter

Stichwörter der Autor:innen

AMR surveillanceESKAPEEEnterobacter spp.Europecarbapenemases

Autor:innen und Institutionen

  • Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Department of Medical Microbiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

ORCID-Profile: Ivana Cirkovic, Snezana Brkic

Förderung

  • Ministry of Science, Technological Development and Innovation, the Republic of Serbia

Zitieren

APA

Cirkovic, I., & Brkic, S. (2025). Beyond the Spotlight: Enterobacter spp. as Overlooked Carbapenemase Producers in Europe. Antibiotics, 14(10), 1045. https://doi.org/10.3390/antibiotics14101045

Vancouver

Cirkovic I, Brkic S. Beyond the Spotlight: Enterobacter spp. as Overlooked Carbapenemase Producers in Europe. Antibiotics. 2025;14(10):1045. doi:10.3390/antibiotics14101045

BibTeX
@article{Cirkovic2025,
  author = {Cirkovic, Ivana and Brkic, Snezana},
  title = {Beyond the Spotlight: Enterobacter spp. as Overlooked Carbapenemase Producers in Europe},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1045},
  doi = {10.3390/antibiotics14101045}
}
Kostenlos starten →